Biotechnology Cancer Cures Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Biotechnology Cancer Cures

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rollcast... who wrote (14)	4/12/1999 12:09:00 AM
From: Mike McFarland	of 226

sesquiterpene gamma lactone from a species of wormwood endemic to the Karaganda region of Kazakstan I wouldn't presume to judge the abstract, too many big words;-) But you showed me yours...I'll show what I grabbed for my turn... Magainin, MAGN Squalamine...a steroid-related aminosterol, is presently undergoing Phase I clinical trials in advanced cancer patients In a Sqalamine abstract I found triple combination therapy produced a TGI of 95.7% (3/10 animals) and a tumor shrinkage of 54.8% (4/10 animals) compared to the TGI of 55.9% and no tumor shrinkage without the addition of squalamine. So what the heck? You have to have a little fun with the stocks too right? Cant just sink it all into a promising platform company and wait for a decade--although that is mostly what I think a person should do. But the Kazakstan wormwood sounds way cool...just the sort of thing to get written up in the Times...especially if they have data for 300 humans...but I could not find anything on Recap.com...and the abstract only mentioned 'cultures of human tumor cells'...if you have something more than that please post. In the meantime I'll PM some stuff to you.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next